Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Vogel

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Science Signaling|March 31, 2016
JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitorsSizhi P Gao, Qing Chang, Ninghui Mao, et al.
Journal of Extracellular Vesicles|September 30, 2016
A standardized method to determine the concentration of extracellular vesicles using tunable resistive pulse sensingRobert Vogel, Frank A W Coumans, Raluca G Maltesen, et al.
Journal of the American College of Cardiology|January 18, 2020
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary SyndromeVera A Bittner, Michael Szarek, Philip E Aylward, et al.
Circulation|May 24, 2019
Effect of Alirocumab on Mortality After Acute Coronary SyndromesPhilippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, et al.
Nature Communications|October 26, 2018
A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infectionSlim Fourati, Aarthi Talla, Mehrad Mahmoudian, et al.
Nature Communications|June 19, 2019
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screenMichael P Menden, Dennis Wang, Mike J Mason, et al.
American Heart Journal|April 29, 2008
The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart StudyBraxton D Mitchell, Patrick F McArdle, Haiqing Shen, et al.
Circulation|October 15, 2003
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part IIMorteza Naghavi, Peter Libby, Erling Falk, et al.
Circulation|October 8, 2003
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part IMorteza Naghavi, Peter Libby, Erling Falk, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Science Signaling|March 31, 2016
JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitorsSizhi P Gao, Qing Chang, Ninghui Mao, et al.
Journal of Extracellular Vesicles|September 30, 2016
A standardized method to determine the concentration of extracellular vesicles using tunable resistive pulse sensingRobert Vogel, Frank A W Coumans, Raluca G Maltesen, et al.
Journal of the American College of Cardiology|January 18, 2020
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary SyndromeVera A Bittner, Michael Szarek, Philip E Aylward, et al.
Circulation|May 24, 2019
Effect of Alirocumab on Mortality After Acute Coronary SyndromesPhilippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, et al.
Nature Communications|October 26, 2018
A crowdsourced analysis to identify ab initio molecular signatures predictive of susceptibility to viral infectionSlim Fourati, Aarthi Talla, Mehrad Mahmoudian, et al.
Nature Communications|June 19, 2019
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screenMichael P Menden, Dennis Wang, Mike J Mason, et al.
American Heart Journal|April 29, 2008
The genetic response to short-term interventions affecting cardiovascular function: rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart StudyBraxton D Mitchell, Patrick F McArdle, Haiqing Shen, et al.
Circulation|October 15, 2003
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part IIMorteza Naghavi, Peter Libby, Erling Falk, et al.
Circulation|October 8, 2003
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part IMorteza Naghavi, Peter Libby, Erling Falk, et al.
Pageof 9